Oxaliplatin Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Report ID: 1905 | Published Date: Jan 2025 | No. of Page: 130 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
Table of Contents
1  RESEARCH SCOPE
    1.1 Research Product Definition
    1.2 Research Segmentation
        1.2.1 Product Type
        1.2.2 Main product Type of Major Players
    1.3 Demand Overview
    1.4 Research Methodology
2 GLOBAL OXALIPLATIN INDUSTRY
    2.1 Summary about Oxaliplatin Industry
    2.2 Oxaliplatin Market Trends
        2.2.1 Oxaliplatin Production & Consumption Trends
        2.2.2 Oxaliplatin Demand Structure Trends
    2.3 Oxaliplatin Cost & Price
3  MARKET DYNAMICS
    3.1 Manufacturing & Purchasing Behavior in 2020
    3.2 Market Development under the Impact of COVID-19
        3.2.1 Drivers
        3.2.2 Restraints
        3.2.3 Opportunity
        3.2.4 Risk
4  GLOBAL MARKET SEGMENTATION
    4.1 Region Segmentation (2017 to 2021f)
        4.1.1 North America (U.S., Canada and Mexico)
        4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
        4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
        4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
        4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
    4.2 Product Type Segmentation (2017 to 2021f)
        4.2.1 Mannitol
        4.2.2 Glucose solution
        4.2.3 Lactose solution
        4.2.4 Others
    4.3 Consumption Segmentation (2017 to 2021f)
        4.3.1 Colorectal cancer
        4.3.2 Stomach cancer
        4.3.3 Ovarian cancer
        4.3.4 Others
5  NORTH AMERICA MARKET SEGMENT
    5.1 Region Segmentation (2017 to 2021f)
        5.1.1 U.S.
        5.1.2 Canada
        5.1.3 Mexico
    5.2 Product Type Segmentation (2017 to 2021f)
        5.2.1 Mannitol
        5.2.2 Glucose solution
        5.2.3 Lactose solution
        5.2.4 Others
    5.3 Consumption Segmentation (2017 to 2021f)
        5.3.1 Colorectal cancer
        5.3.2 Stomach cancer
        5.3.3 Ovarian cancer
        5.3.4 Others
    5.4 Impact of COVID-19 in North America
6  EUROPE MARKET SEGMENTATION
    6.1 Region Segmentation (2017 to 2021f)
        6.1.1 Germany
        6.1.2 UK
        6.1.3 France
        6.1.4 Italy
        6.1.5 Rest of Europe
    6.2 Product Type Segmentation (2017 to 2021f)
        6.2.1 Mannitol
        6.2.2 Glucose solution
        6.2.3 Lactose solution
        6.2.4 Others
    6.3 Consumption Segmentation (2017 to 2021f)
        6.3.1 Colorectal cancer
        6.3.2 Stomach cancer
        6.3.3 Ovarian cancer
        6.3.4 Others
    6.4  Impact of COVID-19 in Europe
7  ASIA-PACIFIC MARKET SEGMENTATION
    7.1 Region Segmentation (2017 to 2021f)
        7.1.1 China
        7.1.2 India
        7.1.3 Japan
        7.1.4 South Korea
        7.1.5 Southeast Asia
        7.1.6 Australia
        7.1.7 Rest of Asia Pacific
    7.2 Product Type Segmentation (2017 to 2021f)
        7.2.1 Mannitol
        7.2.2 Glucose solution
        7.2.3 Lactose solution
        7.2.4 Others
    7.3 Consumption Segmentation (2017 to 2021f)
        7.3.1 Colorectal cancer
        7.3.2 Stomach cancer
        7.3.3 Ovarian cancer
        7.3.4 Others
    7.4  Impact of COVID-19 in Europe
8  SOUTH AMERICA MARKET SEGMENTATION
    8.1 Region Segmentation (2017 to 2021f)
        8.1.1 Brazil
        8.1.2 Argentina
        8.1.3 Rest of Latin America
    8.2 Product Type Segmentation (2017 to 2021f)
        8.2.1 Mannitol
        8.2.2 Glucose solution
        8.2.3 Lactose solution
        8.2.4 Others
    8.3 Consumption Segmentation (2017 to 2021f)
        8.3.1 Colorectal cancer
        8.3.2 Stomach cancer
        8.3.3 Ovarian cancer
        8.3.4 Others
    8.4  Impact of COVID-19 in Europe
9  MIDDLE EAST AND AFRICA MARKET SEGMENTATION
    9.1 Region Segmentation (2017 to 2021f)
        9.1.1 GCC
        9.1.2 North Africa
        9.1.3 South Africa
        9.1.4 Rest of Middle East and Africa
    9.2 Product Type Segmentation (2017 to 2021f)
        9.2.1 Mannitol
        9.2.2 Glucose solution
        9.2.3 Lactose solution
        9.2.4 Others
    9.3 Consumption Segmentation (2017 to 2021f)
        9.3.1 Colorectal cancer
        9.3.2 Stomach cancer
        9.3.3 Ovarian cancer
        9.3.4 Others
    9.4  Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
    10.1 Brief Introduction of Major Players
        10.1.1 Sanofi-Aventis
        10.1.2 Yakult honsha
        10.1.3 Dr Reddy's laboratories
        10.1.4 Sun Pharmaceutical
        10.1.5 Teva
        10.1.6 Fresenius Kabi
        10.1.7 Hospira
        10.1.8 Mylan
        10.1.9 Jiangsu Hengrui Medicine
        10.1.10 Nanjing Pharmaceutical Factory
        10.1.11 Jiangsu Aosaikang Pharmaceutical
        10.1.12 Qilu Pharmaceutical
        10.1.13 Hisun Pharmaceutical
        10.1.14 Lunan Pharmaceutical
        10.1.15 Luoxin
        10.1.16 Halfsky Pharmacy
        10.1.17 YRPG
        10.1.18 Hainan Jinrui Pharmaceutical
        10.1.19 Jari Pharmaceutical
        10.1.20 Chiatai Tianqing
    10.2  Oxaliplatin Sales Date of Major Players (2017-2020e)
        10.2.1 Sanofi-Aventis
        10.2.2 Yakult honsha
        10.2.3 Dr Reddy's laboratories
        10.2.4 Sun Pharmaceutical
        10.2.5 Teva
        10.2.6 Fresenius Kabi
        10.2.7 Hospira
        10.2.8 Mylan
        10.2.9 Jiangsu Hengrui Medicine
        10.2.10 Nanjing Pharmaceutical Factory
        10.2.11 Jiangsu Aosaikang Pharmaceutical
        10.2.12 Qilu Pharmaceutical
        10.2.13 Hisun Pharmaceutical
        10.2.14 Lunan Pharmaceutical
        10.2.15 Luoxin
        10.2.16 Halfsky Pharmacy
        10.2.17 YRPG
        10.2.18 Hainan Jinrui Pharmaceutical
        10.2.19 Jari Pharmaceutical
        10.2.20 Chiatai Tianqing
    10.3  Market Distribution of Major Players
    10.4 Global Competition Segmentation
11  MARKET FORECAST
    11.1  Forecast by Region
    11.2  Forecast by Demand
    11.3  Environment Forecast
        11.3.1  Impact of COVID-19
        11.3.2  Geopolitics Overview
        11.3.3  Economic Overview of Major Countries
12  REPORT SUMMARY STATEMENT
List of Table
1.Table Oxaliplatin Product Type Overview
2.Table Oxaliplatin Product Type Market Share List
3.Table Oxaliplatin Product Type of Major Players
4.Table Brief Introduction of Sanofi-Aventis
5.Table Brief Introduction of Yakult honsha
6.Table Brief Introduction of Dr Reddy's laboratories
7.Table Brief Introduction of Sun Pharmaceutical
8.Table Brief Introduction of Teva
9.Table Brief Introduction of Fresenius Kabi
10.Table Brief Introduction of Hospira
11.Table Brief Introduction of Mylan
12.Table Brief Introduction of Jiangsu Hengrui Medicine
13.Table Brief Introduction of Nanjing Pharmaceutical Factory
14.Table Brief Introduction of Jiangsu Aosaikang Pharmaceutical
15.Table Brief Introduction of Qilu Pharmaceutical
16.Table Brief Introduction of Hisun Pharmaceutical
17.Table Brief Introduction of Lunan Pharmaceutical
18.Table Brief Introduction of Luoxin
19.Table Brief Introduction of Halfsky Pharmacy
20.Table Brief Introduction of YRPG
21.Table Brief Introduction of Hainan Jinrui Pharmaceutical
22.Table Brief Introduction of Jari Pharmaceutical
23.Table Brief Introduction of Chiatai Tianqing
24.Table Products & Services of Sanofi-Aventis
25.Table Products & Services of Yakult honsha
26.Table Products & Services of Dr Reddy's laboratories
27.Table Products & Services of Sun Pharmaceutical
28.Table Products & Services of Teva
29.Table Products & Services of Fresenius Kabi
30.Table Products & Services of Hospira
31.Table Products & Services of Mylan
32.Table Products & Services of Jiangsu Hengrui Medicine
33.Table Products & Services of Nanjing Pharmaceutical Factory
34.Table Products & Services of Jiangsu Aosaikang Pharmaceutical
35.Table Products & Services of Qilu Pharmaceutical
36.Table Products & Services of Hisun Pharmaceutical
37.Table Products & Services of Lunan Pharmaceutical
38.Table Products & Services of Luoxin
39.Table Products & Services of Halfsky Pharmacy
40.Table Products & Services of YRPG
41.Table Products & Services of Hainan Jinrui Pharmaceutical
42.Table Products & Services of Jari Pharmaceutical
43.Table Products & Services of Chiatai Tianqing
44.Table Market Distribution of Major Players
45.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
46.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
47.Table Global Oxaliplatin Market Forecast (Million USD) by Region 2021f-2026f
48.Table Global Oxaliplatin Market Forecast (Million USD) Share by Region 2021f-2026f
49.Table Global Oxaliplatin Market Forecast (Million USD) by Demand 2021f-2026f
50.Table Global Oxaliplatin Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure
1.Figure Global Oxaliplatin Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Oxaliplatin Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Oxaliplatin Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Oxaliplatin Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Oxaliplatin Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Oxaliplatin Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Oxaliplatin Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure Mannitol Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure Glucose solution Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Lactose solution Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure Colorectal cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure Stomach cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure Ovarian cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Mannitol Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Glucose solution Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure Lactose solution Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure Colorectal cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure Stomach cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure Ovarian cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure Mannitol Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Glucose solution Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure Lactose solution Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Colorectal cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure Stomach cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure Ovarian cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure Mannitol Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Glucose solution Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure Lactose solution Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure Colorectal cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure Stomach cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure Ovarian cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure Mannitol Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Glucose solution Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure Lactose solution Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
66.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
67.Figure Colorectal cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
68.Figure Stomach cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
69.Figure Ovarian cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
70.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
71.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
72.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
73.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
74.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
75.Figure Mannitol Segmentation Market Size (USD Million) 2017-2021f and Year-ove
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Oxaliplatin Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Oxaliplatin Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Oxaliplatin Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports